DIPG patient-derived neurospheres showed high levels of BMI-1 protein, thereby providing an in vitro system to investigate the role of BMI-1 in DIPG and to test its validity as a therapeutic target. This evidence concerns the gene BMI1 and diffuse intrinsic pontine glioma.